Acorah Software Products - Accounts Production 16.5.460 false true 31 January 2024 1 February 2023 false true No description of principal activity 1 February 2024 31 January 2025 31 January 2025 11747180 Abel Gebremeskel iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11747180 2024-01-31 11747180 2025-01-31 11747180 2024-02-01 2025-01-31 11747180 frs-core:CurrentFinancialInstruments 2025-01-31 11747180 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 11747180 frs-bus:FilletedAccounts 2024-02-01 2025-01-31 11747180 frs-bus:Micro-entities 2024-02-01 2025-01-31 11747180 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 11747180 frs-bus:Director1 2024-02-01 2025-01-31 11747180 2023-01-31 11747180 2024-01-31 11747180 2023-02-01 2024-01-31 11747180 frs-core:CurrentFinancialInstruments 2024-01-31
Registered number: 11747180
Abelif Pharma Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2025
Mazuma
Balance Sheet
Registered number: 11747180
2025 2024
£ £
Fixed assets 1,731 1,557
Current assets 74,488 73,480
Creditors: Amounts Falling Due Within One Year (12,434 ) (24,154 )
NET CURRENT ASSETS 62,054 49,326
TOTAL ASSETS LESS CURRENT LIABILITIES 63,785 50,883
NET ASSETS 63,785 50,883
CAPITAL AND RESERVES 63,785 50,883

Notes

1. General Information
Abelif Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11747180 . The registered office is Flat 10 34-36 Harrington Road, London, SW7 3ND.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Abel Gebremeskel
Director
29/10/2025